For additional confirmation, we treated two MYCN-amplified neuroblastoma cell lines, IMR-5 and LS, with the BET bromodomain inhibitor JQ1 in order to inhibit MYCN (Fig. 4g). This evidence concerns the gene MYCN and neuroblastoma.